BIOTECH AND LIFE SCIENCES
Biotech AI needs a research trail.
In a life-sciences company, the sensitive file is not always a patient record. Sometimes it is an assay result, a partner deck, a protocol draft, a patent idea, or the quiet reasoning behind a programme decision.
AI can help prepare the work. The company still needs to know what data was touched, which model route was used, who reviewed the output, and what record remains when quality, security, legal, a partner, or an executive asks.
THE RESEARCH QUESTION
Useful AI cannot become a second lab notebook nobody can inspect.
Research teams already live with review trails: protocols, change histories, study files, quality records, partner diligence, and board updates. AI should fit that discipline instead of creating an informal reasoning layer beside it.
Vantage Workspace gives AI-assisted research operations a customer-owned place to happen: files, mail, chat, documents, meetings, AI Workers, model routes, prompt firewall outcomes, and audit trail inside one boundary.
The practical question is not whether AI can summarize papers or draft a first protocol note. It can. The question is whether the company can explain what data the draft touched, who reviewed it, and where the record lives afterwards.
GOOD FIRST WORKFLOWS
Start where AI helps the team prepare work, not decide science.
- Literature and patent-landscape summaries for scientist review.
- Protocol, SOP, and study-document drafting with human approval.
- Internal research notes and experiment-context summaries.
- Vendor, CRO, and partner due-diligence preparation.
- Regulatory, quality, and security evidence packs for review teams.
- Cross-functional coordination across research, clinical operations, quality, and leadership.
WHAT GOOD LOOKS LIKE
The workspace has to protect the reasoning, not just the file.
Good life-sciences AI behaves like supervised research operations: bounded, reviewed, attributable, and attached to the record.
AI Workers work inside a customer-owned workspace rather than a personal model account.
Research files, mail, chat, documents, meetings, and evidence stay inside one operating boundary.
Model routes can be selected by policy, including public LLM routes only where the customer permits them.
The AI firewall scans prompts before they reach a model, with outcomes attached to the record.
Human review remains explicit before work reaches a regulator, patient-facing pathway, partner, CRO, or system of record.
The audit trail can show who asked, what was touched, which route was used, who confirmed, and what changed.
THE FIVE-QUESTION TEST
Ask these before AI touches research data.
- Which research and IP-sensitive data is in bounds for each workflow?
- Can the company show which named user caused AI to touch a research file?
- Which outputs can be drafted by AI but must be reviewed before use?
- Where does the prompt, output, review, and approval record live?
- Can the same evidence satisfy security, quality, privacy, partner, and executive review?
BOUNDARIES
What this page is not claiming.
- This is not a clinical decision system and does not replace scientific or medical judgment.
- This is not a substitute for GxP validation, quality-system ownership, or regulatory-submission responsibility.
- This is not a lab-instrument control system or electronic lab notebook replacement by itself.
- This is not a public explanation of restricted security internals. Outcomes are public; deep mechanisms stay restricted.
BEST FIRST STEP
Bring one research workflow and one evidence question.
In twenty minutes, map what AI would touch, which route it should use, who reviews the work, and what record the life-sciences team needs afterwards.